Document is current
Any future updates will be listed below
-
Authors
Pang, Jing https://orcid.org/0000-0002-9700-6948
Barnett, Wendy
Purdie, Jane
Della-Vedova, Jennifer A.
Woodward, Annmarie
Bell, Damon A.
Hooper, Amanda J. https://orcid.org/0000-0002-2171-1288
Chan, Dick C.
Martin, Andrew C.
Nowak, Kristen J.
Garton-Smith, Jacquie https://orcid.org/0000-0001-6012-5209
Watts, Gerald F. https://orcid.org/0000-0003-2276-1524
-
Funding
Funding for this research was provided by:
Amgen
Department of Health, Government of Western Australia
Royal Perth Hospital Medical Research Foundation
Department of Health | National Health and Medical Research Council
- License Information
-
More Information
Article History
Received: 3 July 2025
Revised: 21 October 2025
Accepted: 3 November 2025
First Online: 17 November 2025
Competing interests
: G.F.W. has received honoraria for advisory boards, lectures, or research grants from Amgen, Arrowhead, CSL Seqirus, Esperion, Novartis, Novo Nordisk and Sanofi. All other authors have no relevant disclosures.
: The investigation was considered an evaluation of a clinical service and approval was granted by the Governance, Evidence, Knowledge and Outcomes (GEKO) Medical Division Committee of the Royal Perth Hospital (Quality Activity 49329); the satisfaction survey was also approved by the GEKO Clinical Services Division Committee (Quality Activity 57986).
